Improving
Evidence And Outcomes In Health Care Decision Making
In Asia Pacific: Challenge To A New Era.
MONDAY 6
MARCH 2006
8:00-8:20
Welcome from Fudan University
Auditorium (Chinese translation available)
Shanlian Hu, MD. MPH, Program Co-Chair and Professor, School
of Public Health, Fudan University, Shanghai, P.R. China Wen Chen, PhD, Program Co-Chair and Professor, Associate
Dean, School of Public Health, Fudan University, Shanghai,
P.R. China Veiping Wang, Professor and Vice-President, Fudan
University, Shanghai, P.R. China
8:20-8:30
Welcome from Chinese Medical Doctor Association Auditorium (Chinese translation available)
Jing Jang, Chairman and Secretary General
8:30-8:45
Welcome from ISPOR Auditorium (Chinese translation available)
Peter Neumann ScD, 2005-2006 ISPOR President,
Professor and Director, Center for the Evaluation of Value
and Risk in Health, Tufts University School of Medicine,
Boston, MA, USA Michael Drummond PhD, 2005-2006 ISPOR
President-elect, and Professor of Health Economics, Centre
of Health Economics, University of York, Heslington, York,
UK Isao Kamae MD, DrPH, 2004-2006 ISPOR Board of
Directors and Professor, Graduate School of Medicine, Kobe
University, Kobe, Japan Marilyn Dix Smith RPh, PhD, ISPOR Founding
Executive Director on ISPOR Past, Present and Future
8:45-9:00
Welcome from ISPOR Asia Consortium Auditorium (Chinese translation available)
Gordon G. Liu PhD, 2004-2006 Chair, ISPOR Asia
Consortium Executive Committee, Professor and Chair,
Department of Health Economics and Management, Guanghua
School of Management, Peking University, Beijing, P.R.
China Kenneth KC Lee JP, BSc (Pharm), MPhil, PhD,
2004-2006 Chair-elect and Professor, School of Pharmacy,
Faculty of Medicine, The Chinese University of Hong Kong
Hong Li PhD, MPH, 2005-2007 Chair, ISPOR Asia
Consortium Advisory Committee and Director, OR-ROW
Liaison, Department of Global Epidemiology and Outcomes
Research, Bristol-Myers Squibb Company, Wallingford, CT,
USA Jeff J. Guo PhD, 2005-2007 Chair-elect, ISPOR Asia
Consortium Advisory Committee, Associate Professor of
Pharmacoepidemiology and Pharmacoeconomics, College of
Pharmacy, and Faculty Research Fellow, Institute for
Health Policy and Health Service Research, University of
Cincinnati Medical Center, Cincinnati, OH, USA
Jinfu Chen, Deputy Director, Department Of medical Insurance, Ministry of Labor and
Social Security, P.R. China
9:20-9:30
Break
Coffee & Tea supported by China Chemical & Pharmaceutical
Co., Ltd.
9:30-11:00
First Plenary Session
Auditorium (Chinese translation available)
PHARMACOECONOMIICS AND OUTCOMES RESEARCH IN ASIA-PACIFIC: CHINA, JAPAN, SOUTH KOREA, SINGAPORE, THAILAND, PAKISTAN,
MALAYSIA AND INDIA
This presentation will examine the use of
pharmacoeconomics and outcomes research in health care
decisions in China, Japan, South Korea, Singapore,
Thailand, Pakistan Malaysia and India. The session
moderator will present key information common to all
countries, which includes information of demographics,
health care, health care insurance and health care
expenditure and controls (
Click here to see country specific information ) . Speakers from each country will
discuss core issues in their countries, including problems
and experience in the use of the science of
pharmacoeconomics.
Moderator:
Tony Yen-Huei Tarn, PhD,
Director, Department
of Pharmacy, Taipei City Hospital, Taipei, Taiwan
Biographical Info
Speakers: Shanlian Hu MD, MSc ,
Professor, School of Public Health, Fudan University, Shanghai, P.R. China
Biographical target="_blank"fo Isao Kamae MD, DrPH,
Professor, Graduate School of Medicine, Kobe University,
Kobe, Japan Biographical
Info Bong-Min Yang PhD
Professor of Economics and
Dean, School of Public Health, Seoul National University,
Seoul, South Korea
Biographical Info Shu-Chuen Li PhD, MS, MBA ,
Associate
Professor, Department of Pharmacy, National University of
Singapore, Singapore
Biographical Info Viroj Tangcharoensathien PhD,
Director of International Health Policy Program, Ministry
of Public Health, Thailand
Biographical
Info Aamir Hameed FCPS, MBBS, BSc,
Senior Instructor & Consultant Cardiologist, Department of
Medicine, The Aga Khan University, and Member of the
Scientific Council on Atherosclerosis and Thrombosis of
the Pakistan Cardiac Society for STEMI Guidelines Task
Force, Karachi, Pakistan Biographical Info Syed Mohamed Aljunid PhD, MD, MSc,
FAMM,
Professor and Head, Department of Community Health, Universiti Kebangsaan Malaysia (UKM), Kuala Lumpur,
Malaysia
Biographical Info Jawahar S. Bapna PhD, MD, MB, Professor,
Pharmaceutical Management India Institute of Health
Management Research, Jaipur, India Biographical Info
11:00-11:15
Break
Coffee & Tea supported by China Chemical & Pharmaceutical
Co., Ltd.
11:15-12:15
Podium Session I
Moderator: Hsiao-Yi Lin MD, Rheumatologist, Taipei
Veteran General Hospital; Associate Professor of National
Yang-Ming University, Taipei, Taiwan
Moderator: Tae-Jin Lee PhD, Assistant Professor, Department of Social & Preventive Medicine, College of Medicine, Hallym University, Chuncheon, South Korea
DB3
THE CORE DIABETES MODEL – SIMULATING LONG-TERM EFFECTS OF
IMPLEMENTING HEALTH POLICIES FOR MANAGEMENT OF DIABETES Ray JA, Palmer A, Valentine WJ, Lurati FM, Foos V,
Minshall ME, Roze S
EDUCATIONAL SYMPOSIUM (ALL ARE INVITED TO ATTEND)Auditorium
Sponsored by Benefits Design Institute with a grant
from Sanofi-Aventis
EVIDENCE-BASED POLICY AND BENEFIT DESIGN FOR HEALTH
CARE VALUE
Schumarry H. Chao, MD MBA, Clinical Professor,
University of Southern California and Co-Executive
Director, Benefits Design Institute; Peter Neumann ScD,
Professor of Medicine, Tufts School of Medicine and
Director, Center for Evaluation of Value and Risk in
Health Institute for Clinical Research and Health Policy
Studies; Gordon Liu PhD, Professor and Chair,
Department of Health Economics and Management, Peking
University and University of North Carolina.
Due to intense market competition and escalating
health care costs, payers are increasingly pressured to
contain costs. While evidence-based outcome research is
central to quantifying value and optimizing resources, it
is often not considered in actual policy and “real world”
reimbursement decisions. This session explores the gaps
and innovative models in US for integrating outcome
research into policy and benefit design decisions to
optimize value to consumers, payers, and society.
Speakers will discuss US experience and implications for
China.
W4 ADAPTING MODELS TO ASIA Shanghai Room 6 Discussion Leaders: Bruce Crawford MA, MPH,
Senior Project Director, Mapi Values, Boston, MA, USA;
Takashi Fukuda PhD, Associate Professor, University of
Tokyo, Tokyo, Japan; Eui Kyung Lee PhD, Director,
Korea Institute for Health and Social Affairs (KIHASA),
Seoul, South Korea
W7 APPLICATIONS OF OUTCOMES RESEARCH IN THE ASIAN
MARKET AND COMMONICATING THE RESULTS Auditorium (Chinese translation available)
Discussion Leaders: Bruce Crawford MA, MPH,
Senior Project Director, Mapi Values, Boston, MA, USA;
LillianYu-Jen Wang MSc, Health Economics and Market
Access Manager, Boehringer Ingelheim Taiwan Limited,
Taipei, Taiwan; Michael Stanley BA, Director,
Adelphi Targis, Tokyo, Japan
W8 PAYOR ORIENTED EVIDENCE GUIDELINES Shanghai Room 5
Discussion Leader: Joseph Singer MD, Co-Chair
VBR POEM Working Group, HealthCore, Inc, Wilmington, DE,
USA
OUTCOMES RESEARCH METHODS
W9 INTERPRETATION OF COST-EFFECTIVENESS RESULTS IN ASIA Shanghai Room 1
Discussion Leaders: Bruno Jolain MD, Director
Health Economics Intercontinental Region,
Sanofi-Synthelabo, Gentilly Cedex, France; Bong-Min
Yang PhD, Professor of Economics and Dean, School of
Public Health, Seoul National University, Seoul, South
Korea; Nathorn Chaiyakunapruk PharmD, PhD,
Assistant Professor, Department of Pharmacy Practice,
Naresuan University, Pitsanuloak, Thailand
Coffee & Tea supported by China Chemical & Pharmaceutical
Co., Ltd.
16:30-17:30
Co-Sponsor
Special Sessions I
OUTCOMES RESEARCH ON
DRUG PRICING AND REIMBURSEMENT IN CHINA
Auditorium (Chinese translation available)
Peter Scheuer, Executive Director, R&D-based
Pharmaceutical Association Committee, R&D Pharmaceutical
Association of China (invited)
HEALTH CARE DELIVERY AND
REIMBURSEMENT POLICIES IN PAKISTAN
Shanghai Room 1 Aamir Hameed FCPS, MBBS, BSc, Senior Instructor &
Consultant Cardiologist, Department of Medicine, The Aga
Khan University, and Member of the Scientific Council on
Atherosclerosis and Thrombosis of the Pakistan Cardiac
Society for STEMI guidelines task force
EVIDENCE-BASED MEDICINE AND
HEALTH TECHNOLOGY ASSESSMENT IN SOUTH KOREA
Shanghai Room 2 Sang Moo Lee MD, PhD, Director, Health Technology
Assessment System Development Group, and Medical
Consultant, Health Insurance Review Agency, Korea Seong-Hi Park PhD, Director, Health Technology
Assessment Team in Health Insurance Review Agency, South
Korea
ISPOR LOCAL CHAPTERS OUTCOMES
RESEARCH INITIATIVES Shanghai Room 6
Moderator: Jawahar S. Bapna, PhD, MD, MB,
Professor, Pharmaceutical management, India Institute of
Health Isao Kamae, MD, DrPH, President, ISPOR Japan
Chapter and Professor, Graduate School of Medicine, Kobe
University, Kobe, Japan Tony Yen-Huei Tarn, PhD, President, ISPOR Taiwan
Chapter and Director, Department of Pharmacy, Taipei City
Hospital, Taipei, Taiwan Wen Chen PhD, Professor and Dean Associate, School
of Public Health, Fudan University, P.R. China Vitaya Kulsomboon PhD, President, ISPOR Thailand
Chapter and Assistant Professor and Chair of Social
Social Pharmacy Department, Faculty of Pharmaceutical
Sciences, Chulalongkorn University, Patumwan, Bangkok,
Thailand
Hong Kong Hall 1 All poster presentation authors MUST be with their posters.
See Poster
Presentations
17:30-18:30
Poster Presentation Author Hour Hong Kong Hall 1
18:30-19:30
Special Discussion Auditorium
CHINA PHARMACOECONOMICS
GUIDELINES (In Chinese) Shanlian Hu MD, MSc, Professor, School of Public Health, Fudan University, Shanghai, P.R. China
18:30-19:30
ISPOR Asia Consortium Business Meeting
(By Invitation Only) Shanghai Room 1
19:30-21:30
FUDAN UNIVERSITY DINNER & ENTERTAINMENT (ALL ARE INVITED TO ATTEND)
Dinner supported by ROCHE CHINA
Grand Ballroom, First Floor
19:30-20:00/font>
ROCHE (CHINA) PRESENTATION (hors d’oevres
served) Grand Ballroom, First Floor
Peter Neumann ScD, 2005-2006 ISPOR President
and Professor and Director, Center for the
Evaluation of Value and Risk in Health, Tufts
University School of Medicine, Boston, MA, USA
20:00-21:30
DINNER AND
ENTERTAINMENTGrand Ballroom, First
Floor
